BB vs LCTX · P/E 117, rev $549.1M vs rev $9.5M
BlackBerry Ltd (BB) versus Lineage Cell Therapeutics Inc (LCTX) — a side-by-side from cached financials, not a winner call.
BlackBerry Ltd (BB) is a software - infrastructure company listed on US.
Lineage Cell Therapeutics Inc (LCTX) is a biotechnology company listed on US.
Latest reported BB revenue for 2026-02-28 was $549.1M. Net income was $53.2M. Revenue was up 2.7% from 2025-02-28 to 2026-02-28. BB currently screens at market cap $6.14B and trailing P/E 116.5.
Latest reported LCTX revenue for 2024-12-31 was $9.5M. Net income was -$18.6M. Revenue was up 354.9% from 2023-12-31 to 2024-12-31. LCTX currently screens at market cap $213.6M.
BB currently screens at market cap $6.14B and trailing P/E 116.5. LCTX currently screens at market cap $213.6M.
Not investment advice. Open the BB and LCTX stock pages for the full models.
Not investment advice.